In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...

The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, researchers say.

"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

However, clotting can sometimes be a problem; aspirin reduces the amount of the clotting protein, called thromboxane A2 (TXA2), produced. Previous research60209-8) had suggested that taking a low dose ...

The new research suggests a path for aspirin to become a cancer treatment - but people are being warned not to start taking ...

Scientists share how they discovered that aspirin could potentially help to prevent cancer spread in the body.

The scientists traced signals in the cell to determine that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2).

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response.